Fototerapia – metoda wykorzystywana w leczeniu przewlekłych schorzeń dermatologicznych
References
- Singer S., Berneburg M.: Phototherapy. J. Dtsch. Dermatol. Ges., 2018; 16: 1120-1129
- Nagy E.M., Dalla Via L., Ronconi L., Fregona D.: Recent advances in PUVA photochemotherapy and PDT for the treatment of cancer. Curr. Pharm. Des., 2010; 16: 1863-1876
- Ackroyd R., Kelty C., Brown N., Reed M.: The history of photodetection and photodynamic therapy. Photochem. Photobiol., 2001; 74: 656-669
- Duarte I., Buense R., Kobata C.: Phototherapy. An. Bras. Dermatol., 2006; 81: 74-82
- Matsumura Y., Ananthaswamy H.N.: Toxic effects of ultraviolet radiation on the skin. Toxicol. Appl. Pharmacol., 2004; 195: 298-308
- Bailey E.E., Ference E.H., Alikhan A., Hession M.T., Armstrong A.W.: Combination treatments for psoriasis: A systematic review and meta-analysis. Arch. Dermatol., 2012; 148: 511-522
- Mohania D., Chandel S., Kumar P., Verma V., Digvijay K., Tripathi D., Choudhury K., Mitten S.K., Shah D.: Ultraviolet radiations: Skin defense-damage mechanism. Adv. Exp. Med. Biol., 2017; 996: 7187
- Young A.R., Claveau J., Rossi A.B.: Ultraviolet radiation and the skin: Photobiology and sunscreen photoprotection. J. Am. Acad. Dermatol., 2017; 76: 100-109
- Ibbotson S.H.: A perspective on the use of NB-UVB phototherapy vs. PUVA photochemotherapy. Front. Med., 2018; 5: 184
- Jiang A.J., Lim H.W.: Phototherapy in the evaluation and management of photodermatoses. Dermatol. Clin., 2020; 38: 71-77
- Juarez M.C., Grossberg A.L.: Phototherapy in the pediatric population. Dermatol. Clin., 2020; 38: 91-108
- Maitray A., Rishi P.: Methoxsalen-induced macular toxicity. Indian J. Ophthalmol., 2017; 65: 1243-1245
- Klimas K., Fischer A.: Reakcja fototoksyczna i czynniki ją wywołujące. Alergologia Info, 2018; 4: 83-88
- Bulat V., Situm M., Dediol I., Ljubicić I., Bradić L.: The mechanisms of action of phototherapy in the treatment of the most common dermatoses. Coll. Antropol., 2011; 35: 147-151
- Maleki M., Yazdanpanah M.J., Hamidi H., Jokar L.: Evaluation of PUVA-induced skin side effects in patients referred to the Imam Reza Hospital of Mashhad in 2005-2007. Indian J. Dermatol., 2014; 59: 209
- Briganti S., Wlaschek M., Hinrichs C., Bellei B., Flori E., Treiber N., Iben S., Picardo M., Scharffetter-Kochanek K.: Small molecular antioxidants effectively protect from PUVA-induced oxidative stress responses underlying fibroblast senescence and photoaging. Free Radic. Biol. Med., 2008; 45: 636-44
- Turbay S., Piro O.E., Echeverría G.A., Navarro A., Fernández-Liencres M.P., Fortuna M., Tuttolomondo M.E.: Theoretical and experimental study of a novel psolaren derivate: (E)-9-(3,4-dimethylpent-2-enyloxy)-7H-furo[3,2-g]chromen-7-one. Spectrochim. Acta A. Mol. Biomol. Spectrosc., 2014; 123: 71-77
- Bartnik M., Mazurek A.K.: Isolation of methoxyfuranocoumarins from Ammi majus by centrifugal partition chromatography. J. Chromatogr. Sci., 2016; 54: 10-16
- Salińska M., Kowalska H., Torzecka J.D., Waszczykowska E., Woźniacka A.: Phototoxic reaction due to solar radiation exposure in a psoriatic patient treated with PUVA therapy. Med. Pr., 2019; 70: 763-768
- Kemény L., Varga E., Novak Z.: Advances in phototherapy for psoriasis and atopic dermatitis. Expert Rev. Clin. Immunol,. 2019; 15: 1205-1214
- Khanna N., Nazli T., Siddiqui K.M., Kalaivani M., Rais-ur-Rahman.: A non-inferiority randomized controlled clinical trial comparing Unani formulation & psoralen plus ultraviolet A sol in chronic plaque psoriasis. Indian J. Med. Res., 2018; 147: 66-72
- Ware O.R., Guiyab J., Okoye G.A.: Phototherapy in skin of color. Dermatol. Clin., 2020; 38: 63-69
- Richard E.G.: The science and (lost) art of psoralen plus UVA phototherapy. Dermatol. Clin., 2020; 38: 11-23
- Sadowska M., Lesiak A., Narbutt J.: Application of phototherapy in the treatment of psoriasis vulgaris. Dermatol. Rev., 2019; 106: 198-209
- Farahnik B., Nakamura M., Singh R.K., Abrouk M., Zhu T.H., Lee K.M., Jose M.V., DaLovisio R., Koo J., Bhutani T., Liao W.: The patient’s guide to psoriasis treatment. Part 2: PUVA phototherapy. Dermatol. Ther., 2016; 6: 315-324
- Errichetti E., Piccirillo A., Ricciuti F., Ricciuti F.: Steroid-resistant localized lymphomatoid papulosis treated with local bath-PUVA therapy. Indian J. Dermatol., 2013; 58: 163
- Kubo R., Muramatsu S., Sagawa Y., Saito C., Kasuya S., Nishioka A., Nishida E., Yamazaki S., Morita A.: Bath-PUVA therapy improves impaired resting regulatory T cells and increases activated regulatory T cells in psoriasis. J. Dermatol. Sci., 2017; 86: 46-53
- Elmets C.A., Lim H.W., Stoff B., Connor C., Cordoro K.M., Lebwohl M., Armstrong A.W., Davis D.M., Elewski B.E., Gelfand J.M. i wsp.: Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy. J. Am. Acad. Dermatol., 2019; 81:775-804
- Yu Z., Wolf P.: How it works: The immunology underlying phototherapy. Dermatol. Clin., 2020; 38: 37-53
- Zhang P., Wu M.X.: A clinical review of phototherapy for psoriasis. Lasers Med. Sci., 2018; 33: 173-180
- El-Zawahry B.M., Elmasry M.F., Ragab A.: The role of long-wavelength ultraviolet A1 (UVA1) in acral vitiligo. J. Cosmet. Dermatol., 2019; 18:1155-1160
- Zhang T., Shen Z., Zheng J., Jiang R.: Effect of UVA1 on hypertrophic scarring in the rabbit ear model. Biosci. Rep., 2020; 40: BSR20190007
- Keyal U., Bhatta A.K, Wang X.L.: UVA1 a promising approach for scleroderma. Am. J. Transl. Res., 2017; 9: 4280-4287
- Connolly K.L., Griffith J.L., McEvoy M., Lim H.W.: Ultraviolet Al phototherapy beyond morphea: Experience in 83 patients. Photodermatol. Photoimmunol. Photomed., 2015; 31: 289-295
- Prasad S., Coias J., Chen H.W., Jacobe H.: Utilizing UVA-1 phototherapy. Dermatol. Clin., 2020; 38: 79-90
- Pacifico A., Iacovelli P., Damiani G., Ferraro C., Cazzaniga S., Conic R.R., Leone G., Morrone A.: ‘High dose’ vs. ‘medium dose’ UVA1 phototherapy in italian patients with severe atopic dermatitis. J. Eur. Acad. Dermatol. Venereol., 2019; 33: 718-724
- Kohli I., Braunberger T.L., Nahhas A.F., Mirza F.N., Mokhtari M., Lyons A.B., Kollias N., Ruvolo E., Lim H.W., Hamzavi I.H.: Long-wavelength ultraviolet A1 and visible light photoprotection: A multimodality assessment of dose and response. Photochem. Photobiol., 2020; 96: 208-214
- Khanna U., Khandpur S.: What is new in narrow-band ultraviolet-B therapy for vitiligo? Indian Dermatol. Online J., 2019; 10: 234243
- Mehta D., Lim H.W.: Ultraviolet B phototherapy for psoriasis: Review of practical guidelines. Am. J. Clin. 2016; 17: 125-133
- Pacifico A., Damiani G., Iacovelli P., Conic R.R., Scarabello A., Filoni A., Malagoli P., Bragazzi N.L., Pigatto P.D., Morrone A.: Photoadaptation to UVB TL01 in psoriatic patients. J. Eur. Acad. Dermatol. Venereol., 2020; 34: 1750-1754
- Rajpara A.N., O’Neill J.L., Dermatol., Nolan B.V., Yentzer B.A., Feldman S.R.: Review of home phototherapy. Dermatol. Online J., 2010; 16: 2
- Lozinski A., Barzilai A., Pavlotsky F.: Broad-band UVB versus paint PUVA for palmoplantar psoriasis treatment. J. Dermatolog. Treat., 2016; 27: 221-223
- Köster W., Wiskemann A.: Phototherapy with UV-B in vitiligo. Z. Hautkr., 1990; 65: 1022-1024, 1029
- Doghaim N.N., El-Tatawy R.A., Ismail M.A., Ali D.A.M., El Attar Y.A.: Study the effect of erbium:YAG laser plus topical 5‐flurouracil in stable vitiligo resistant to NB‐UVB phototherapy. J. Cosmet. Dermatol., 2020; 19: 122-130
- Khater M.H., AbdallaAlhabib S., Elkshishy K.A., Khattab F.M.: Evaluation of Galectin3 levels in psoriatic patients treated by narrow-band UVB phototherapy. J. Dermatolog. Treat., 2020; 31: 758-762
- Ortiz-Salvador J.M., Pérez-Ferriols A.: Phototherapy in atopic dermatitis. Adv. Exp. Med. Biol., 2017; 996: 279-286
- Khemis A., Fontas E., Moulin S., Montaudié H., Lacour J.P., Passeron T.: Apremilast in combination with narrowband UVB in the treatment of vitiligo: A 52-week monocentric prospective randomized placebo-controlled study. J. Invest. Dermatol., 2020; 140: 1533-1537.e2
- Silpa-Archa N., Weerasubpong P., Junsuwan N., Yothachai P., Supapueng O., Wongpraparut C.: Treatment outcome and persistence of repigmentation from narrow-band ultraviolet B phototherapy in vitiligo. J. Dermatolog. Treat., 2019; 30: 691-696
- Ocampo-Garza J., Salinas-Santander M., Welsh O., Herz-Ruelas M., Ocampo-Candiani J.: Expression of melanocortin 1 receptor before and after narrowband UVB phototherapy treatment in patients with stable vitiligo: A prospective study. Exp. Ther. Med., 2020; 19: 1649-1654
- Arora C.J., Rafiq M., Shumack S., Gupta M.: The efficacy and safety of tacrolimus as mono- and adjunctive therapy for vitiligo: A systematic review of randomised clinical trials. Australas. J. Dermatol., 2020; 61: e1-e9
- Thompson K.G., Kim N.: Distinguishing myth from fact: Photocarcinogenesis and phototherapy. Dermatol. Clin., 2020; 38: 25-35
- Esmat S., Hegazy R.A., Shalaby S., Hu S.C., Lan C.E.: Phototherapy and combination therapies for vitiligo. Dermatol. Clin., 2017; 35: 171-192
- Shirasu N., Nam S.O., Kuroki M.: Tumor-targeted photodynamic therapy. Anticancer Res., 2013; 33: 2823-2831
- Luo D., Carter K.A., Miranda D., Lovell J.F.: Chemophototherapy: An emerging treatment option for solid tumors. Adv. Sci., 2016; 4: 1600106
- Rkein A.M., Ozog D.M.: Photodynamic therapy. Dermatol. Clin., 2014; 32: 415-425
- Kwaśny M.: Metoda fotodynamicznego leczenia w dermatologii. Forum Dermatol., 2018; 4: 138-147
- Rojkiewicz M., Kozik W., Czapka M., Jarzembek K., Zięba G., Kuś P., Kozik V.: Fotodynamiczna terapia nowotworów. Probl. Ekol., 2010; 14: 196-204
- Kessel D., Oleinick N.L.: Photodynamic therapy and cell death pathways. Methods Mol. Biol., 2010; 635: 35-46
- Buytaert E., Dewaele M., Agostinis P.: Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim. Biophys. Acta., 2007; 1776: 86-107
- Chilakamarthi U., Giribabu L.: Photodynamic therapy: Past, present and future. Chem. Rec., 2017; 17: 775-802
- Moriwaki K., Sawada T., Akiyama M., Ikeda A., Kikuchi J., Matsumura T., Yano S., Katayoka H., Inoue M., Akashi H.: Synthesis and photophysical properties of S-mannosylated chlorins and their effect on photocytotoxicity in HeLa cells. Bull. Chem. Soc. Jpn., 2018; 91: 230-236
- Yoon I., Li J.Z., Shim Y.K.: Advance in photosensitizers and light delivery for photodynamic therapy. Clin. Endosc., 2013; 46: 7-23
- Kwiatkowski S., Knap B., Przystupski D., Saczko J., Kędzierska E., Knap-Czop K., Kotlińska J., Michel O., Kotowski K., Kulbacka J.: Photodynamic therapy – mechanisms, photosensitizers and combinations. Biomed. Pharmacother., 2018; 106: 1098-1107
- Babilas P., Schreml S., Landthaler M., Szeimies R.M.: Photodynamic therapy in dermatology: State-of-the-art. Photodermatol. Photoimmunol. Photomed., 2010; 26: 118-132
- Prażmo E.J., Kwaśny M., Łapiński M., Mielczarek A.: Photodynamic therapy as a promising method used in the treatment of oral diseases. Adv. Clin. Exp. Med., 2016; 25: 799-807
- Minchinton A.I., Tannock I.F.: Drug penetration in solid tumors. Nat. Rev. Cancer, 2006; 6: 583-592
- Fang J., Nakamura H., Maeda H.: The EPR effect: Unique features of tumour blood vessels for drug delivery, factors involved and limitations and augmentation of the effect. Adv. Drug Deliv. Rev., 2011; 63: 136-151
- Maeda H.: Tumor-selective delivery of macromolecular drugs via the EPR effect: Background and future prospects. Bioconjug. Chem., 2010; 21: 797-802
- Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R.: Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol., 2007; 2: 751-760
- Agostinis P., Berg K., Cengel K.A., Foster T.H., Girotti A.W., Gollnick S.A., Hahn S.M., Hamblin M.R., Juzeniene A., Kessel D. i wsp.: Photodynamic therapy of cancer: An update. CA Cancer J. Clin., 2011; 61: 250-281
- Allison R.R.: Photodynamic therapy: Oncologic horizons. Future Oncol., 2014; 10: 123-124
- Kou J., Dou D., Yang L.: Porphyrin photosensitizers in photodynamic therapy and its applications. Oncotarget, 2017; 8: 8159181603
- Allison R.R., Mota H.C., Sibata C.H.: Clinical PD/PDT in North America: An historical review. Photodiagnosis Photodyn. Ther., 2004; 1: 263-277
- Kessel D.: More adventures in photodynamic therapy. Int. J. Mol. Sci., 2015; 16: 15188-15193
- Dolmans D., Fukumura D., Jain R.K.: Photodynamic therapy for cancer. Nat. Rev. Cancer, 2003; 3: 380-387
- Zeitouni N.C., Oseroff A.R., Shieh S.: Photodynamic therapy for nonmelanoma skin cancers. Current review and update. Mol. Immunol., 2003; 39: 1133-1136
- Pariser D.M., Lowe N.J., Stewart D.M., Jarratt M.T., Lucky A.W., Pariser R.J., Yamauchi P.S.: Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: Results of a prospective randomized multicenter trial. J. Am. Acad. Dermatol., 2003; 48: 227-232
- Szeimies R.M., Karrer S., Radakovic-Fijan S., Tanew A., Calzavara-Pinton P.G., Zane C., Sidoroff A., Hempel M., Urlich J., Proebstle T. i wsp.: Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. J. Am. Acad. Dermatol., 2002; 47: 258-262
- Kang H.K., Yun J.H., Son Y.M., Roh J.Y., Lee J.R.: Photodynamic therapy for Bowen’s disease of the vulva area. Ann. Dermatol., 2014; 26: 241-245
- Fiechter S., Skaria A., Nievergelt H., Anex R., Borradori L., Parmentier L.: Facial basal cell carcinomas recurring after photodynamic therapy: A retrospective analysis of histological subtypes. Dermatology., 2012; 224: 346-351
- Griffin L., Lear J.T.: Photodynamic therapy and non-melanoma skin cancer. Cancers, 2016; 8: 98
- Zane C., Capezzera R., Sala R., Venturini M., Calzavara-Pinton P.: Clinical and echographic analysis of photodynamic therapy using methylaminolevulinate as sensitizer in the treatment of photodamaged facial skin. Lasers Surg. Med., 2007; 39: 203-209
- Hayami J., Okamoto H., Sugihara A., Horio T.: Immunosuppressive effects of photodynamic therapy by topical aminolevulinic acid. J. Dermatol., 2007; 34: 320-327
- Boen M., Brownell J., Patel P., Tsoukas M.M.: The role of photodynamic therapy in acne: An evidence-based review. Am. J. Clin. Dermatol., 2017; 18: 311-321
- Jugeau S., Tenaud I., Knol A.C., Jarrousse V., Quereux G., Khammari A., Dreno B.: Induction of toll-like receptors by Propionibacterium acnes. Br. J. Dermatol., 2005; 153: 1105-1113
- Steinbauer J.M., Schreml S., Kohl E.A., Karrer S., Landthaler M., Szeimies R.M.: Photodynamic therapy in dermatology. J. Dtsch. Dermatol. Ges., 2010; 8: 454-464
- Klein A., Balibas P., Karrer S., Landthaler M., Szeimies R.M.: Photodynamic therapy in dermatology – an update. J. Dtsch. Dermatol. Ges., 2008; 6: 839-845
- Gold M.H., Bradshaw V.L., Boring M.M., Bridges T.M., Biron J.A.: Split-face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage. Dermatol. Surg., 2006; 32: 795-801
- Zane C., Venturini M., Sala R., Calzavara-Pinton P.: Photodynamic therapy with methylaminolevulinate as a valuable treatment option for unilesional cutaneous T-cell lymphoma. Photodermatol. Photoimmunol. Photomed., 2006; 22: 254-258
- Carrascosa J.M.: Fototerapia y fotoquimioterapia. Actas Dermosifiliogr., 2004; 95: 259-284
DOI: https://doi.org/10.2478/ahem-2021-0010 | Journal eISSN: 1732-2693
Language: English
Page range: 873 - 888
Submitted on: May 27, 2020
Accepted on: Jun 25, 2021
Published on: Dec 27, 2021
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Related subjects:
© 2021 Klaudia Banach, Marta Karkoszka, Dorota Wrześniok, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.